Zobrazeno 1 - 10
of 177
pro vyhledávání: '"Bernhard Tribukait"'
Autor:
Bernhard Tribukait, Per-Olof Lundgren, Anders Kjellman, Ulf Norming, Claes R. Nyman, Kiran Jagarlmundi, Ove Gustafsson
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 6, p 5160 (2023)
Thymidine kinase 1 (TK1) is an intracellular enzyme involved in DNA-precursor synthesis. Increased serum TK1 levels are used as a biomarker in various malignancies. We combined serum TK1 with PSA and evaluated its capacity to predict overall survival
Externí odkaz:
https://doaj.org/article/ba289c399e284670be55629a14649d18
Autor:
Bernhard Tribukait
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background After neoadjuvant chemotherapy of breast cancer pathologic complete response (pCR) indicates a favorable prognosis. Among non-selected patients, pCR is, however, achieved in only 10–30%. Early evaluation of tumour response to tr
Externí odkaz:
https://doaj.org/article/93987dcf03e0406ca27b43b52f91f25c
Autor:
Bernhard Tribukait
Publikováno v:
Cancers, Vol 13, Iss 21, p 5442 (2021)
Pathologic complete response (pCR) predicts the long-term outcome of neoadjuvantly treated (NAC) breast cancer (BC) but is reached in p = 0.005), and DFS was 90.7% and 68% (p = 0.006), respectively. Thus, the response of sTK1 at the first cycle of ch
Externí odkaz:
https://doaj.org/article/43f23180dbdf4735be547d759721b756
Autor:
Helma Motherby, Natalia Pomjanski, Mary Kube, Alexandra Boros, Thomas Heiden, Bernhard Tribukait, Alfred Böcking
Publikováno v:
Analytical Cellular Pathology, Vol 24, Iss 1, Pp 5-15 (2002)
Aims: To determine the sensitivity and specificity of flow‐ and image‐cytometry for the detection of DNA‐aneuploidy as a marker for malignant cells in effusions. Methods: 200 effusions (80 tumor cell‐positive, 74 negative and 46 cytologically
Externí odkaz:
https://doaj.org/article/860aacc0af5a490cb07c550f2f5b630f
Autor:
Ulf Gustafsson, Curt Einarsson, Lennart C. Eriksson, Virgil Gadaleanu, Staffan Sahlin, Bernhard Tribukait
Publikováno v:
Analytical Cellular Pathology, Vol 23, Iss 3-4, Pp 143-152 (2001)
Gallstones are a risk factor for the development of gallbladder cancer. We studied DNA ploidy and cell cycle composition by flow cytometry in archival specimens from 52 gall bladder carcinomas in relation to histopathological grade, tumour stage, gal
Externí odkaz:
https://doaj.org/article/7bc96e50dd8844c1880bdcd6583754b6
Publikováno v:
Analytical Cellular Pathology, Vol 23, Iss 1, Pp 11-19 (2001)
The cytosolic thymidine kinase 1 (TK1) is one of the enzymes involved in DNA replication. Based on biochemical studies, TK1 is activated at late G1 of cell cycle, and its activity correlates with the cell proliferation. We have developed a polyclonal
Externí odkaz:
https://doaj.org/article/3d0f7b9a0a704eb7abecbb508092bb10
Publikováno v:
Analytical Cellular Pathology, Vol 20, Iss 1, Pp 49-62 (2000)
Background. Heterogeneity of prostate carcinoma is one of the reasons for pretreatment underestimation of tumor aggressiveness. We studied tumor heterogeneity and the probability of finding the highest tumor grade and DNA aneuploidy with relation to
Externí odkaz:
https://doaj.org/article/3549dc6861f549b88cc71089a60f4596
Autor:
Per‐Olof Lundgren, Bernhard Tribukait, Anders Kjellman, Ulf Norming, Kiran Jagarlmudi, Ove Gustafsson
Background Thymidine kinase 1 (TK1) recycles DNA before cell division. We do not know if baseline blood concentrations of TK1 predict death in prostate cancer within 30 years. Our objective is to determine if there is an association between baseline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c738a5ee26b56a706267d18aaf9c0bc
https://pub.epsilon.slu.se/29439/
https://pub.epsilon.slu.se/29439/
Publikováno v:
World Journal of Urology
Purpose The aim of this prospective study was to identify the tumour characteristics that are associated with invasiveness and those that are relevant for disease-specific survival (DSS) in upper tract urothelial carcinoma, UTUC. Methods From a prosp
Background: After neoadjuvant chemotherapy of breast cancer pathologic complete response (pCR) indicates a favourable prognosis. Among non-selected patients, pCR is, however, achieved in only 10-30%. Early evaluation of tumour response to treatment w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a31867e0dbbd6e85b0c2d539e26fe03
https://doi.org/10.21203/rs.2.13682/v1
https://doi.org/10.21203/rs.2.13682/v1